Your browser doesn't support javascript.
loading
Intravitreal anti-VEGF treatment for subretinal neovascularisation secondary to type 2 idiopathic juxtafoveolar telangiectasia.
Barth, Teresa; Zeman, Florian; Helbig, Horst; Gamulescu, Maria-Andreea.
Affiliation
  • Barth T; Department of Ophthalmology, University Medical Centre Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany. teresa.barth@ukr.de.
  • Zeman F; Centre for Clinical Studies (ZKS), University Medical Centre Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.
  • Helbig H; Department of Ophthalmology, University Medical Centre Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.
  • Gamulescu MA; Department of Ophthalmology, University Medical Centre Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.
Int Ophthalmol ; 38(1): 191-198, 2018 Feb.
Article in En | MEDLINE | ID: mdl-28108904
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Retina / Telangiectasia, Hereditary Hemorrhagic / Retinal Neovascularization / Vascular Endothelial Growth Factor A / Bevacizumab / Ranibizumab Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Retina / Telangiectasia, Hereditary Hemorrhagic / Retinal Neovascularization / Vascular Endothelial Growth Factor A / Bevacizumab / Ranibizumab Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2018 Type: Article